Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rodgers

Showing results (791-800 of 805) with videos related to

Pageof 81
Sort By:
Human Reproduction Open|September 6, 2019
Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertilityM F Costello, M L Misso, A Balen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 21, 2010
Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analysesJeffrey L Lennox, Edwin Dejesus, Daniel S Berger, et al.
Multiple Sclerosis and Related Disorders|October 15, 2021
COVID-19 in Multiple Sclerosis: Clinically reported outcomes from the UK Multiple Sclerosis RegisterR M Middleton, E M Craig, W J Rodgers, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|September 13, 2019
A brief update on the evidence supporting the treatment of infertility in polycystic ovary syndromeMichael F Costello, Marie L Misso, Adam Balen, et al.
Spine|February 4, 2016
Breaking Through the "Glass Ceiling" of Minimally Invasive Spine SurgeryFrank M Phillips, Ivan Cheng, Y Raja Rampersaud, et al.
Faraday Discussions|November 20, 2014
Role of surface contaminants, functionalities, defects and electronic structure: general discussionRichard McCreery, Chi-Chang Hu, Julie Macpherson, et al.
Lancet (London, England)|January 16, 2010
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trialsJoseph J Eron, Benjamin Young, David A Cooper, et al.
Environmental Geochemistry and Health|July 3, 2020
The Society for Environmental Geochemistry and Health (SEGH): building for the future of early career researchersO S Humphrey, D R S Middleton, S Ahmad, et al.
Nature Communications|May 26, 2021
INPP4B promotes PI3Kα-dependent late endosome formation and Wnt/β-catenin signaling in breast cancerSamuel J Rodgers, Lisa M Ooms, Viola M J Oorschot, et al.
The Lancet. Infectious Diseases|September 22, 2011
Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trialJoseph J Eron, Jürgen K Rockstroh, Jacques Reynes, et al.
Pageof 81

Showing results (791-800 of 805) with videos related to

Sort By:
Pageof 81
Human Reproduction Open|September 6, 2019
Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertilityM F Costello, M L Misso, A Balen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 21, 2010
Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analysesJeffrey L Lennox, Edwin Dejesus, Daniel S Berger, et al.
Multiple Sclerosis and Related Disorders|October 15, 2021
COVID-19 in Multiple Sclerosis: Clinically reported outcomes from the UK Multiple Sclerosis RegisterR M Middleton, E M Craig, W J Rodgers, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|September 13, 2019
A brief update on the evidence supporting the treatment of infertility in polycystic ovary syndromeMichael F Costello, Marie L Misso, Adam Balen, et al.
Spine|February 4, 2016
Breaking Through the "Glass Ceiling" of Minimally Invasive Spine SurgeryFrank M Phillips, Ivan Cheng, Y Raja Rampersaud, et al.
Faraday Discussions|November 20, 2014
Role of surface contaminants, functionalities, defects and electronic structure: general discussionRichard McCreery, Chi-Chang Hu, Julie Macpherson, et al.
Lancet (London, England)|January 16, 2010
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trialsJoseph J Eron, Benjamin Young, David A Cooper, et al.
Environmental Geochemistry and Health|July 3, 2020
The Society for Environmental Geochemistry and Health (SEGH): building for the future of early career researchersO S Humphrey, D R S Middleton, S Ahmad, et al.
Nature Communications|May 26, 2021
INPP4B promotes PI3Kα-dependent late endosome formation and Wnt/β-catenin signaling in breast cancerSamuel J Rodgers, Lisa M Ooms, Viola M J Oorschot, et al.
The Lancet. Infectious Diseases|September 22, 2011
Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trialJoseph J Eron, Jürgen K Rockstroh, Jacques Reynes, et al.
Pageof 81